Quetiapine ('Seroquel') has equivalent efficacy and superior tolerability to risperidone in treating the negative symptoms of schizophrenia

被引：0
|
作者：
Riedel, M
Müller, N
Strassnig, M
Spellmann, I
Müller-Arends, A
Dehning, S
Sadowsky, N
机构：
[1] Munich Univ Hosp, Munich, Germany
[2] Univ Pittsburgh, Med Ctr, Western Psychiat Inst & Clin, Pittsburgh, PA 15260 USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S414 / S414
页数：1
相关论文
共 50 条
  • [41] The efficacy of zotepine in treating acute negative symptoms of schizophrenia: The results of a meta-analysis
    Wighton, A
    Tweed, JA
    Butler, A
    Welch, CP
    Reynolds, C
    Bratty, JR
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2000, 4 (03) : 209 - 214
  • [42] Comparative efficacy of flupentixol and risperidone on schizophrenic negative symptoms
    Philipp, M
    Lesch, OM
    Schmauss, M
    Dose, M
    Glaser, T
    PSYCHIATRISCHE PRAXIS, 2003, 30 : S94 - S96
  • [43] Safety and tolerability of olanzapine versus risperidone:: a one-year randomized study in outpatients with schizophrenia with prominent negative symptoms
    Ciudad, A.
    Alvarez, E.
    Bousono, M.
    Olivares, J. M.
    Gomez, J. C.
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2007, 35 (02): : 105 - 114
  • [44] Influence of risperidone very small doses on the negative symptoms in schizophrenia
    Tys, SM
    Vlokh, IY
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 300 - 300
  • [45] Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis
    Moteshafi, Hoda
    Stip, Emmanuel
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (05) : 713 - 732
  • [46] Comparison of efficacy and tolerability of quetiapine and haloperidol in acute exacerbation of chronic or subchronic schizophrenia
    Taneli, B
    Alptekin, K
    Bilici, M
    Birsoz, S
    Eker, E
    Cosar, B
    Goka, E
    Goktepe, E
    Guz, H
    Karamustafalioglu, O
    Kultur, S
    Levent, BA
    Onder, E
    Oral, T
    Ozsahin, AÖ
    Veznedaroglu, B
    Yuksel, S
    Yurtseven, N
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S287 - S287
  • [47] Augmentation with cognitive behavioural therapy has superior efficacy to augmentation with risperidone for treating adults with treatment-resistant OCD
    O'Neill, Joseph
    EVIDENCE-BASED MENTAL HEALTH, 2014, 17 (02) : 58 - 59
  • [48] Efficacy of risperidone in reducing positive and negative symptoms in medication-refractory schizophrenia: An open prospective study
    Smith, RC
    Chua, JW
    Lipetsker, B
    Bhattacharyya, A
    JOURNAL OF CLINICAL PSYCHIATRY, 1996, 57 (10) : 460 - 466
  • [49] Comparison of efficacy and safety between risperidone and quetiapine in schizophrenia and schizoaffective disorder: A pilot study
    Cho, S
    Hahm, B
    Suh, TW
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S413 - S413
  • [50] The effectiveness of quetiapine versus olanzapine in improving negative symptoms of patients with schizophrenia
    Sirota, P
    Tchernichowsky, E
    Panet, I
    Koren, A
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 170 - 170
12345